GSK’s Emma Walmsley to step down as chief executive after eight years

Chief commercial officer Luke Miels to take over as CEO at Britain's second-biggest drugmaker

• Business live - latest updates

Britain's second-biggest drugmaker GSK has announced the departure of its chief executive, Dame Emma Walmsley, after eight years in the top job.

Walmsley, 56, who has run the FTSE 100 company since 2017, will step down from the board at the end of this year, and remain at GSK until her notice period ends on 30 September 2026. It is unclear what she will do then, but she said she had no intention of retiring when she leaves the company.